Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

Clayton Harro, Xiao Sun, Jon E. Stek, Randi Y. Leavitt, Devan V. Mehrotra, Fubao Wang, Andrew J. Bett, Danilo R. Casimiro, John W. Shiver, Mark J. Dinubile, Erin Quirk

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)204
Number of pages1
JournalClinical and Vaccine Immunology
Issue number1
StatePublished - Jan 2010
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this